Sepsis and Septic Shock Flashcards
Sepsis-3 Definition (2016)
Life-threatening organ dysfunction caused by a dysregulated host response to infection
Septic Shock
(Distributive shock)
Subset of sepsis in which profound circulatory, cellular, and metabolic abnormalities are associated with a great risk of mortality
Need for vasopressor to maintain mean arterial pressure (MAP) ≥65 mmHg despite adequate fluid resuscitation
Lactate >2 mmol/L
Fluid Resuscitation
Provide fluid therapy to increase intravascular volume and venous return
Crystalloids
Dynamic
Fluid Resuscitation - Amount of fluid
30 mL/kg within the first 3 hours of resuscitation
Fluid Resuscitation - Type of Fluid
First-line fluid for resuscitation = Crystalloids
When to use albumin for fluid resuscitation?
Patients who already received a significant amount of crystalloids and at risk of volume overload
Which crystalloid is suggested and why?
balanced crystalloids (lactated ringers)
Concern for normal saline and its potential harm related to hyperchloremic metabolic acidosis leading to renal failure
Fluid Resuscitation - Assessment of Fluid Responsiveness
Passive leg raise - Allowing the blood from the legs to act as a fluid bolus back to the heart
MAP
Mean Arterial Pressure
MAP ≥65 mmHg is needed for adequate perfusion
MAP = 1/3 SBP + 2/3 DBP
Lactate
Blood Lactate
Metabolic product of anaerobic metabolism
Biomarker for global tissue hypoxia
Lactate > 2 mmol/L: global hypoperfusion
Initial management of sepsis and septic shock
Surviving Sepsis Campaign (SSC) Hour-1 Bundle
Measure lactate level (Re-measure if initial lactate >2 mmol/L)
Obtain blood and other relevant cultures
Administer broad-spectrum antibiotics
Rapidly administer 30 mL/kg crystalloid for hypotension or lactate ≥4 mmol/L
Start vasopressors if hypotensive during or after fluid resuscitation to maintain mean arterial pressure (MAP) ≥ 65 mmHg
Alpha-1 (α1) Tissue
Vascular smooth muscle
Alpha-1 (α1) Stimulation of Receptor
Vasoconstriction
Beta-1 (ꞵ1) Tissue
Heart
Beta-2 (ꞵ2) Tissue
Bronchial smooth muscle
Vascular smooth muscle
Vasopressin-1 (V1) Tissue
Vascular smooth muscle
Vasopressin-2 (V2) Tissue
Kidneys
Angiotensin-1 (AT-1) Tissue
Vascular smooth muscle
Kidneys
Beta-1 (ꞵ1) Stimulation of Receptor
Increased HR and contractility
Beta-2 (ꞵ2) Stimulation of Receptor
Bronchodilation
Vasodilation
Vasopressin-1 (V1) Stimulation of Receptor
Vasoconstriction
Vasopressin-2 (V2) Stimulation of Receptor
Fluid retention
Angiotensin-1 (AT-1) Stimulation of Receptor
Vasoconstriction
Fluid and sodium retention
Norepinephrine Receptors
α1, ꞵ1
First line Vasopressor
Norepinephrine
Epinephrine Receptors
α1, ꞵ1, ꞵ2
First alternative or an add-on to norepinephrine
Epinephrine
Epinephrine adverse effects
Tachyarrhythmias (beta-1 stimulation)
Lactic acidosis (beta-2 stimulation)
Hyperglycemia (beta-2 stimulation)
Dopamine Receptors
Dose-dependent activity
Low dose (1-3 mcg/kg/min): DA
Medium dose (3-10 mcg/kg/min): ꞵ1
High dose (10-20 mcg/kg/min): α1, ꞵ1
Dopamine place in therapy
Not preferred (risk of arrhythmias)
Phenylephrine Receptors
α1
Phenylephrine place in therapy
In select patients who may not tolerate other vasopressors (e.g. tachyarrhythmia on norepinephrine)
Mostly used as salvage therapy
Vasopressin receptors
V1, V2
Vasopressin place in therapy
Add-on to norepinephrine
To further increase MAP to target
To decrease norepinephrine requirements
Angiotensin II
AT-1, AT-2
Angiotension II place in therapy
Unclear; Reserved for only select patients
Approved indication: septic/distributive shock
Vasopressin Efficacy Monitoring Parameters
Mean arterial pressure (MAP)
Heart rate (HR)
Infusion rates
Resolution of shock (signs and symptoms)
Vasopressin Safety Monitoring Parameters
Line access (central vs. peripheral)
Extravasation (antidote: phentolamine)
Peripheral vasoconstriction
Electrocardiogram (ECG) and telemetry
Adverse events associated with each vasopressor
Vasopressin Adjunct therapies
Corticosteroids
Hydrocortisone 50 mg IV Q6H
For septic shock not responsive to fluid resuscitation and increasing vasopressors
IV Vitamin C
Not Recommended
Supportive Care
VTE Prophylaxis
Stress Ulcer Prophylaxis
Glucose Management
Nutrition Support
(Maybe add more or separate here)